Sort
172,184 grants matching “inflammation”
MicroRNA in Functional Regulation of Endothelial Cells in Response to Flow
$784,276Shu Chien · University Of California, San Diego · R01 · FY2012 · HL
Modulation of innate and adaptive immunity of filoviruses in macaques
$784,263Thomas William Geisbert · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Virulence in Enteroaggregative Escherichia coli
$784,254James P. Nataro · University Of Virginia · R01 · FY2011 · AI
ECPR After Prolonged Cardiac Arrest: Targeting Mechanisms of the No-Reflow
$784,250Robert W Neumar · University Of Michigan At Ann Arbor · R01 · FY2018 · HL
Role of TNF receptor 2 on Pulmonary Group 2 Innate Lymphoid Cells
$784,241Omid Akbari · University Of Southern California · R01 · FY2022 · HL
Role of TNF receptor 2 on Pulmonary Group 2 Innate Lymphoid Cells
$784,241Omid Akbari · University Of Southern California · R01 · FY2023 · HL
Macrophages in Myocardial Infarction
$784,206Nikolaos G Frangogiannis · Albert Einstein College Of Medicine · R01 · FY2025 · HL
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$784,138Alice S Prince · Columbia University Health Sciences · R35 · FY2019 · HL
Impact of microbiota on AIDS-Kaposiâs sarcoma development and therapy
$784,127Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis
$784,116Lacy M. Alexander · Pennsylvania State University, The · R01 · FY2022 · HL
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
$784,076Craig R Cohen · University Of California, San Francisco · R01 · FY2019 · HD
Role of Th17 in Severe and Recurrent C. difficile Infection
$784,076William A Petri · University Of Virginia · R01 · FY2022 · AI
First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain
$784,058David M Wilson · University Of California, San Francisco · R01 · FY2022 · AG
Developing novel therapies to improve blood stem cell transplantation outcomes
$783,992Ramiro Garzon · Ohio State University · R01 · FY2022 · HL
Local B-1 Regulation of Atherosclerosis
$783,960Coleen A McNamara · University Of Virginia · R01 · FY2017 · HL
NINDS CREATE DISCOVERY: Development of dendrimer-N-acetylcysteine for the treatment of neonatal brain injury
$783,954Kannan Rangaramanujam · Johns Hopkins University · U01 · FY2018 · NS
Understanding and Mitigating Vascular Side-Effects Associated with Anti-Amyloid Immunotherapy
$783,917Cynthia A Lemere · Brigham And Women'S Hospital · R01 · FY2025 · NS
Mechanisms of atherosclerotic cardiovascular complications
$783,846Chiara Giannarelli · New York University School Of Medicine · R01 · FY2025 · HL
Mechanisms of atherosclerotic cardiovascular complications in COVID19
$783,846Chiara Giannarelli · New York University School Of Medicine · R01 · FY2023 · HL
Beta3 Integrins - Translation of Molecular Structure to Improved Therapeutics
$783,775Barry Coller · Rockefeller University · R01 · FY2020 · HL
ADMINISTRATIVE CORE, CENTER DIRECTOR, ENRICHMENT PROGRAM
$783,750Ramnik J Xavier · Massachusetts General Hospital · P30 · FY2011 · DK
Immune based interventions for HIV eradication
$783,714Mirko Paiardini · Emory University · R01 · FY2019 · AI
The role of N6-methyladenosine modified RNA in Alzheimer's disease
$783,699Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2024 · AG
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
$783,698Abigail Pulsipher · Glycomira, Llc · R44 · FY2020 · AI
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
$783,685Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2024 · AI